Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/12/1996 | CA2217301A1 Fibroblast growth factor 15 |
12/12/1996 | CA2217229A1 Pineal gland specific gene-1 |
12/12/1996 | CA2217216A1 Human chemokine beta-13 |
12/12/1996 | CA2216912A1 Human g-protein chemokine receptor hdgnr10 |
12/12/1996 | CA2215286A1 Human criptin growth factor |
12/12/1996 | CA2212992A1 Fibroblast growth factor-14 |
12/11/1996 | EP0747707A1 Propoxyphene derivatives for immunoassay reagents |
12/11/1996 | EP0747698A1 Non-denaturing potency assay for somatotropin |
12/11/1996 | EP0747485A1 Production of proteins using homologous recombination |
12/11/1996 | EP0747483A2 Fermentative carotenoid production |
12/11/1996 | EP0747482A2 Hepatitis GB virus recombinant proteins and uses thereof |
12/11/1996 | EP0747481A1 Epstein-Barr virus peptides and antibodies against these peptides |
12/11/1996 | EP0747480A1 Oligonucleotides specific for cytokine signal transducer gp130 mRNA |
12/11/1996 | EP0747394A2 Hepatitis GB virus synthetic peptides and uses thereof |
12/11/1996 | EP0747391A2 Preparation of an acylated protein powder |
12/11/1996 | EP0747390A2 Reducing gelation of a fatty acid acylated protein using a citrate buffer |
12/11/1996 | EP0747066A2 Biocompatible adhesive compositions |
12/11/1996 | EP0746626A1 Method for carbohydrate engineering of glycoproteins |
12/11/1996 | EP0746625A1 Targetable vector particles |
12/11/1996 | EP0746623A1 Promoter from a lipid transfer protein gene |
12/11/1996 | EP0746622A1 Antifungal proteins, dna coding therefor, and hosts incorporating same |
12/11/1996 | EP0746621A1 Expression of proteins on bacterial surface |
12/11/1996 | EP0746612A1 Synthetic polynucleotides |
12/11/1996 | EP0746611A1 METHOD FOR INCREASING PRODUCTION OF DISULFIDE BONDED RECOMBINANT PROTEINS BY $i(SACCHAROMYCES CEREVISIAE) |
12/11/1996 | EP0746605A1 Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity |
12/11/1996 | EP0746569A1 Receptor-binding determinant from leukaemia inhibitory factor |
12/11/1996 | EP0746565A1 Novel bombesin-related peptides |
12/11/1996 | EP0746337A1 Verotoxin pharmaceutical compositions and medical treatments therewith |
12/11/1996 | EP0746333A1 Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv) |
12/11/1996 | EP0746332A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
12/11/1996 | EP0646130B1 Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides |
12/11/1996 | EP0602032A4 Method of preferential labelling of a phycobiliprotein with a second dye to enable multiple color assay. |
12/11/1996 | EP0496832B1 Inhibition of padgem-mediated cell binding |
12/11/1996 | EP0491865B1 Conjugate vaccine for group b streptococcus |
12/11/1996 | EP0437556B1 Substitution analogues of magainin peptides |
12/11/1996 | CN1137826A Method and compositions for treatment of BCR-ABL associated leukemias and other cell proliferative disorders |
12/11/1996 | CN1137806A Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
12/11/1996 | CN1137758A Methods of prolonged suppression of humoral immunity |
12/11/1996 | CN1137757A Compositions and methods for stimulating megakaryocyte growth and differentiation |
12/11/1996 | CN1137751A Hydrophobic preparations |
12/11/1996 | CN1137528A Production process for modified low temp. ethanolic human serum albumin |
12/10/1996 | US5583210 Methods and compositions for controlling plant development |
12/10/1996 | US5583209 Produced by isolation and recombination of human and porcine factor viii |
12/10/1996 | US5583204 Using affinity columns |
12/10/1996 | US5583203 VLA proteins |
12/10/1996 | US5583202 Antigenized antibodies and genes |
12/10/1996 | US5583200 Containing magnesium or calcium ions; storage stability; immunoassay for myocardial infarction |
12/10/1996 | US5583199 Obtained from cytoplasmic or nuclear eukaryotic cell fractions, induced in hemopoietic factor-dependent cell lines by cytokine |
12/10/1996 | US5583116 Applying a polynucleotide primer to the colony tumor cell |
12/10/1996 | US5583111 Water soluble leech extract |
12/10/1996 | US5583108 Vasonatrin peptide and analogs thereof |
12/10/1996 | US5583107 Agents affecting thrombosis and hemostasis |
12/10/1996 | US5583103 Inhibition of transforming growth factor beta activity |
12/10/1996 | US5583102 Human thrombomodulin in wound healing |
12/10/1996 | US5583046 Polypeptides |
12/10/1996 | US5583040 Mutation of repA protein |
12/10/1996 | US5583038 Bacterial expression vectors containing DNA encoding secretion signals of lipoproteins |
12/10/1996 | US5583036 From somatic cells; genetic engineering |
12/10/1996 | US5583031 Produced by expressing dna encoding alpha and beta polypeptides in insect cell |
12/10/1996 | US5583028 Recombinant vaccinia virus as DNA constructs encoding HSV glycoproteins |
12/10/1996 | US5583021 Genetic engineering |
12/10/1996 | US5583013 Expression in a microorganism transformed with a replicable cloning vehicle; encoding dna is under the operative control of an expression control region |
12/10/1996 | US5583011 Compositions, treatments, and diagnostics for Schistosomiasis and related diseases |
12/10/1996 | US5583010 Nucleic acid molecule encoding the porcine growth hormone receptor |
12/10/1996 | US5583009 Insertion of vertebrate gene locus control regions linked to a structural gene of interest; cistron promoter; agonist; gene expression |
12/10/1996 | US5583002 Determining the level of expression of at least one selected t-cell antigen receptor protein or a protein in the t-lymnphocyte signal transduction pathway |
12/10/1996 | US5582999 Methods for inhibition of intracellular transcription factor |
12/10/1996 | US5582995 Methods of screening for compounds which inhibit the direct binding of Ras to Raf |
12/10/1996 | US5582990 Nucleotide sequence which codes antigen used for detection of lyme disease |
12/10/1996 | US5582989 Multiplex genomic DNA amplification for deletion detection |
12/10/1996 | US5582988 Precipitaion of nucleic acid and cation polymer at acidic ph; adjustment of ph to release nucleic acid |
12/10/1996 | US5582987 Determining whether nucleotides of drb3 gene exon 2 contain codons that encode a glutamic acid at position 70 and an arginine at position 71 |
12/10/1996 | US5582986 Oligonucleotide targeted to codon 12 of human h-ras gene, complementary and hybridizes to messenger rna to interfere with normal role in cell, causing loss of function |
12/10/1996 | US5582972 Antisense oligonucleotides to the RAS gene |
12/10/1996 | US5582969 Mycobacteriophage specific for the mycobacterium tuberculosis complex |
12/10/1996 | US5582968 For immunoassay |
12/10/1996 | US5582826 Monoclonal antibodies which bind the gamma chain of human interleukin-2 receptor |
12/10/1996 | US5582824 Recombinant DES-CYS-TYR-CYS human immune interferon |
12/10/1996 | US5582823 Methods of treating bacterial inflammation and granulocytopoiesis by administering human pluripotent granulocyte colony-stimulating factor |
12/10/1996 | US5582822 Cyclic administration of purified genetically engineered human interleukins |
12/10/1996 | CA2016659C Stabilized compositions containing epidermal growth factor |
12/10/1996 | CA1338782C Antibodies for use in determining human glycoalbumin |
12/10/1996 | CA1338781C Ligands and methods for augmenting b-cell proliferation |
12/08/1996 | CA2178538A1 Hepatitis gb virus synthetic peptides and uses thereof |
12/08/1996 | CA2178537A1 Hepatitis gb virus recombinant proteins and uses thereof |
12/08/1996 | CA2178526A1 Nucleotide sequence of the mycoplasma genitalium genome, fragments thereof, and uses thereof |
12/07/1996 | CA2178256A1 Oncostatin m induced hematopoiesis |
12/06/1996 | CA2177642A1 Nuclear receptors related to the retinoid receptor x family |
12/05/1996 | WO1996038725A1 Attachment enhanced 293 cells |
12/05/1996 | WO1996038591A1 IMPROVED METHOD FOR OBTAINING FULL-LENGTH cDNA SEQUENCES |
12/05/1996 | WO1996038590A1 Methods and compositions for identifying osteogenic agents |
12/05/1996 | WO1996038586A1 Method for the detection of compounds that modulate the effects of the obese protein |
12/05/1996 | WO1996038581A1 Cloning and expression of dna involved in the biosynthesis of cyclopropanated mycolic acids in mycobacterium tuberculosis |
12/05/1996 | WO1996038579A1 High-affinity oligonucleotide ligands to growth factors |
12/05/1996 | WO1996038576A1 Human oligodendroglial progenitor cell line |
12/05/1996 | WO1996038575A1 A method of expressing and secreting soluble extracellular domains of humain gonadotropin hormone receptors |
12/05/1996 | WO1996038572A1 Promoters |
12/05/1996 | WO1996038571A2 Recombinant polypeptide cytotoxins for cancer treatment |
12/05/1996 | WO1996038570A1 Novel fusion protein recovery and purification methods |
12/05/1996 | WO1996038565A1 RECOMBINANT HERPESVIRUS WITH THE USE OF gB GENE PROMOTER |